vs
Globavend Holdings Ltd（GVH）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Globavend Holdings Ltd的1.4倍（$19.6M vs $13.7M），Globavend Holdings Ltd净利率更高（3.3% vs -177.4%，领先180.7%），Globavend Holdings Ltd同比增速更快（63.7% vs -11.5%），Globavend Holdings Ltd自由现金流更多（$-1.2M vs $-23.1M）
Globavend Holdings Ltd是一家智能无人零售解决方案提供商，主营智能自动售货机的设计、供应与运营，主要服务澳大利亚、新西兰及东南亚区域的零售、快消及企业服务客户，提供软硬件及售后一体化支持。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
GVH vs LAB — 直观对比
营收规模更大
LAB
是对方的1.4倍
$13.7M
营收增速更快
GVH
高出75.1%
-11.5%
净利率更高
GVH
高出180.7%
-177.4%
自由现金流更多
GVH
多$21.9M
$-23.1M
损益表 — Q1 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $19.6M |
| 净利润 | $450.3K | $-34.7M |
| 毛利率 | 10.5% | 48.5% |
| 营业利润率 | 5.8% | -168.5% |
| 净利率 | 3.3% | -177.4% |
| 营收同比 | 63.7% | -11.5% |
| 净利润同比 | -49.9% | -28.8% |
| 每股收益（稀释后） | $6.01 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GVHLAB
| Q3 25 | — | $19.6M | ||
| Q2 25 | — | $21.8M | ||
| Q1 25 | $13.7M | $40.8M | ||
| Q3 24 | — | $22.1M | ||
| Q2 24 | — | $22.5M | ||
| Q1 24 | $8.4M | $45.5M | ||
| Q4 23 | — | $28.2M | ||
| Q3 23 | — | $25.4M |
净利润GVHLAB
| Q3 25 | — | $-34.7M | ||
| Q2 25 | — | $-33.5M | ||
| Q1 25 | $450.3K | $-26.0M | ||
| Q3 24 | — | $-26.9M | ||
| Q2 24 | — | $-45.7M | ||
| Q1 24 | $898.8K | $-32.2M | ||
| Q4 23 | — | $-19.8M | ||
| Q3 23 | — | $-21.0M |
毛利率GVHLAB
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | 10.5% | 48.4% | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | 19.8% | 53.1% | ||
| Q4 23 | — | 47.6% | ||
| Q3 23 | — | 44.0% |
营业利润率GVHLAB
| Q3 25 | — | -168.5% | ||
| Q2 25 | — | -118.1% | ||
| Q1 25 | 5.8% | -80.8% | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | 13.8% | -132.2% | ||
| Q4 23 | — | -75.9% | ||
| Q3 23 | — | -83.5% |
净利率GVHLAB
| Q3 25 | — | -177.4% | ||
| Q2 25 | — | -153.7% | ||
| Q1 25 | 3.3% | -63.8% | ||
| Q3 24 | — | -122.0% | ||
| Q2 24 | — | -203.3% | ||
| Q1 24 | 10.7% | -70.6% | ||
| Q4 23 | — | -70.2% | ||
| Q3 23 | — | -82.8% |
每股收益（稀释后）GVHLAB
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | $6.01 | $-0.07 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | $12.57 | $-0.27 | ||
| Q4 23 | — | $-0.24 | ||
| Q3 23 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $915.2K | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.7M | $399.7M |
| 总资产 | $6.4M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GVHLAB
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | $915.2K | $150.9M | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | $2.5M | $287.1M | ||
| Q4 23 | — | $51.7M | ||
| Q3 23 | — | $79.7M |
总债务GVHLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M | ||
| Q3 23 | — | $64.6M |
股东权益GVHLAB
| Q3 25 | — | $399.7M | ||
| Q2 25 | — | $424.5M | ||
| Q1 25 | $5.7M | $454.6M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | — | $510.3M | ||
| Q1 24 | $4.4M | $577.3M | ||
| Q4 23 | — | $-148.1M | ||
| Q3 23 | — | $-131.7M |
总资产GVHLAB
| Q3 25 | — | $539.6M | ||
| Q2 25 | — | $557.0M | ||
| Q1 25 | $6.4M | $579.6M | ||
| Q3 24 | — | $681.5M | ||
| Q2 24 | — | $708.7M | ||
| Q1 24 | $6.0M | $777.7M | ||
| Q4 23 | — | $323.1M | ||
| Q3 23 | — | $339.3M |
负债/权益比GVHLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-906.3K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.2M | $-23.1M |
| 自由现金流率自由现金流/营收 | -8.8% | -118.1% |
| 资本支出强度资本支出/营收 | 2.2% | 4.5% |
| 现金转化率经营现金流/净利润 | -2.01× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流GVHLAB
| Q3 25 | — | $-22.2M | ||
| Q2 25 | — | $-20.7M | ||
| Q1 25 | $-906.3K | $-30.3M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | — | $-39.0M | ||
| Q1 24 | $-256.6K | $-62.5M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-11.4M |
自由现金流GVHLAB
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | $-1.2M | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | $-730.0K | $-63.3M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-12.3M |
自由现金流率GVHLAB
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | -8.8% | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | -8.7% | -138.9% | ||
| Q4 23 | — | -50.2% | ||
| Q3 23 | — | -48.6% |
资本支出强度GVHLAB
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | 2.2% | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | 5.6% | 1.7% | ||
| Q4 23 | — | 0.3% | ||
| Q3 23 | — | 3.6% |
现金转化率GVHLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.29× | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GVH
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
